Shinpoong Pharmaceutical Co Ltd (KO:019175) — Stock Price
Shinpoong Pharmaceutical Co Ltd (KO:019175) is currently trading at ₩13360.00 KRW, up 3.73% today. Over the past 52 weeks, shares have ranged between ₩10690.00 and ₩28450.00. This page tracks Shinpoong Pharmaceutical Co Ltd's live share price on the KO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Shinpoong Pharmaceutical Co Ltd worth.
Shinpoong Pharmaceutical Co Ltd (019175) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Shinpoong Pharmaceutical Co Ltd's daily closing share price and trading volume on the KO exchange over the past year, giving a clear view of recent price momentum and liquidity.
Shinpoong Pharmaceutical Co Ltd Income Statement — Revenue, Profit & Earnings by Year
Shinpoong Pharmaceutical Co Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Revenue | ₩234.68 Billion | ₩221.09 Billion | ₩200.23 Billion | ₩209.29 Billion | ₩189.24 Billion |
| Cost of Revenue | ₩132.01 Billion | ₩139.29 Billion | ₩119.95 Billion | ₩131.31 Billion | ₩111.85 Billion |
| Gross Profit | ₩102.67 Billion | ₩81.80 Billion | ₩80.28 Billion | ₩77.97 Billion | ₩77.39 Billion |
| Research & Development | ₩10.44 Billion | ₩17.88 Billion | ₩42.28 Billion | ₩30.38 Billion | ₩17.33 Billion |
| SG&A | ₩28.54 Billion | ₩33.91 Billion | ₩36.87 Billion | ₩111.99 Billion | ₩29.95 Billion |
| Total Operating Expenses | ₩220.43 Billion | ₩238.12 Billion | ₩247.62 Billion | ₩131.31 Billion | ₩203.54 Billion |
| Operating Income | ₩14.26 Billion | ₩-17.03 Billion | ₩-47.39 Billion | ₩77.97 Billion | ₩-14.31 Billion |
| EBITDA | — | — | — | — | ₩3.89 Billion |
| EBIT | — | — | — | ₩77.97 Billion | ₩-14.31 Billion |
| Interest Expense | ₩2.69 Billion | ₩2.63 Billion | ₩1.72 Billion | ₩61.42 Million | ₩202.06 Million |
| Income Before Tax | ₩8.45 Billion | ₩-14.62 Billion | ₩-53.44 Billion | ₩-34.78 Billion | ₩-8.99 Billion |
| Income Tax Expense | — | — | — | — | ₩2.54 Billion |
| Net Income | ₩8.83 Billion | ₩-15.39 Billion | ₩-57.33 Billion | ₩-35.38 Billion | ₩-11.58 Billion |
Shinpoong Pharmaceutical Co Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Shinpoong Pharmaceutical Co Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | ₩352.47 Billion | ₩342.09 Billion | ₩350.08 Billion | ₩361.54 Billion | ₩392.58 Billion |
| Total Current Assets | ₩206.74 Billion | ₩189.32 Billion | ₩198.94 Billion | ₩196.54 Billion | ₩227.23 Billion |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | ₩24.07 Billion | ₩14.47 Billion | ₩16.78 Billion | ₩14.23 Billion | ₩65.07 Billion |
| Net Receivables | ₩72.54 Billion | ₩70.16 Billion | ₩73.66 Billion | ₩82.29 Billion | ₩81.86 Billion |
| Inventory | ₩58.48 Billion | ₩55.38 Billion | ₩53.92 Billion | ₩46.90 Billion | ₩47.71 Billion |
| Property, Plant & Equipment | — | — | — | ₩113.76 Billion | ₩116.88 Billion |
| Goodwill | — | — | — | — | — |
| Total Liabilities | ₩81.74 Billion | ₩84.00 Billion | ₩79.30 Billion | ₩30.78 Billion | ₩38.03 Billion |
| Total Current Liabilities | ₩66.91 Billion | ₩75.84 Billion | ₩76.38 Billion | ₩27.17 Billion | ₩28.55 Billion |
| Long-term Debt | ₩11.37 Billion | ₩4.60 Billion | — | — | — |
| Net Debt | ₩7.53 Billion | ₩11.32 Billion | ₩1.20 Billion | — | — |
| Total Stockholder Equity | ₩269.97 Billion | ₩256.82 Billion | ₩269.59 Billion | ₩329.61 Billion | ₩353.49 Billion |
| Retained Earnings | ₩50.77 Billion | ₩38.94 Billion | ₩55.33 Billion | ₩115.83 Billion | ₩139.16 Billion |
Shinpoong Pharmaceutical Co Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Shinpoong Pharmaceutical Co Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₩17.25 Billion | ₩-15.15 Billion | ₩-24.81 Billion | ₩-26.44 Billion | ₩-71.03 Billion |
| Capital Expenditures | ₩3.99 Billion | ₩6.09 Billion | ₩15.03 Billion | ₩6.23 Billion | ₩4.42 Billion |
| Free Cash Flow | ₩13.26 Billion | ₩-21.24 Billion | ₩-39.84 Billion | ₩-32.67 Billion | ₩-76.64 Billion |
| Investing Cash Flow | — | — | — | — | ₩49.03 Billion |
| Financing Cash Flow | — | — | — | — | ₩-6.42 Billion |
| Dividends Paid | — | — | — | — | ₩5.16 Billion |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | ₩11.39 Billion | ₩11.96 Billion | ₩11.91 Billion | ₩12.80 Billion | ₩12.68 Billion |
| Change in Cash | ₩5.45 Billion | ₩-1.81 Billion | ₩2.11 Billion | ₩14.05 Billion | ₩-28.17 Billion |
Shinpoong Pharmaceutical Co Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Shinpoong Pharmaceutical Co Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Mar 31, 2026 | 6.68 | — | — |
| Dec 31, 2025 | 9.00 | — | — |
| Nov 12, 2025 | 124.43 | — | — |
| Aug 12, 2025 | 63.78 | — | — |
| May 14, 2025 | -25.05 | — | — |
| Mar 20, 2025 | -246.55 | — | — |
| Nov 12, 2024 | -1.92 | — | — |
| Aug 14, 2024 | -1.03 | — | — |